GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

CCLA CIO Calls Post-Brexit Tax Ideas 'Backward Thinking'
36:00 - James Bevan, chief investment officer at CCLA Investment Management, talks about potential changes to U.K. taxes in Brexit negotiations and the importance of immigration to the U.K. economy. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
  • What Happens to the Pound in Brexit Negotiations?
  • UBS's Fiotakis Says Investors Look to Hedge French Risk
  • Analyst Wheeler Sees Euro Bank Restructuring Nearly Done